HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression.

AbstractBACKGROUND:
At diagnosis, identification of reliable biological indicators of prognosis to allow stratification of patients according to different risks is an important but still unresolved aspect in the treatment of Ewing sarcoma (EWS) patients. This study aimed to explore the role of miR-34A expression on prognosis of EWS patients.
PATIENTS AND METHODS:
Specimens from 109 patients with non-metastatic EWS treated at the Rizzoli Institute with neoadjuvant chemotherapy (protocols ISG/SSGIII, EW-1, EW-2, EW-REN2, EW-REN3, EW-PILOT) and 17 metastases were studied. Sixty-eight patients (62%) remained disease-free and 41 (38%) relapsed (median follow-up: 67 months, range 9-241 months). Expression of miR-34a and of some of its targets (cyclin D1, bcl-2, SIRT1 and YY1) was evaluated by qRT-PCR using TaqMan MicroRNA Assays and/or by immunohistochemistry on tissue microarrays from the same patients.
RESULTS:
High expression of miR-34a in localized tumors was significantly related to better event-free and overall survival (P = 0.004). Relevance of miR-34a was confirmed by using different calibrators (normal mesenchymal stem cells and different normal tissues). By multivariate Cox regression analysis, low miR-34a expression as well as nontotal necrosis and high levels of lactate dehydrogenase were all confirmed as independent risk factors associated with poor outcome. Expression of miR-34a was lower in metastases than in primary tumors. It inversely correlated with expression of cyclin D1 and Ki-67.
CONCLUSIONS:
By demonstrating its relationship with clinical outcome, we propose evaluation of miR-34a at diagnosis of EWS patients to allow early risk stratification. Validation of these results would nonetheless ultimately need a prospective assessment.
AuthorsM T Marino, A Grilli, C Baricordi, M C Manara, S Ventura, R S Pinca, M Bellenghi, M Calvaruso, G Mattia, D Donati, C Tripodo, P Picci, S Ferrari, K Scotlandi
JournalAnnals of oncology : official journal of the European Society for Medical Oncology (Ann Oncol) Vol. 25 Issue 10 Pg. 2080-2086 (Oct 2014) ISSN: 1569-8041 [Electronic] England
PMID25015333 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© The Author 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: [email protected].
Chemical References
  • Ki-67 Antigen
  • MIRN34 microRNA, human
  • MicroRNAs
  • Cyclin D1
  • Hydro-Lyases
  • lactate dehydratase
Topics
  • Adult
  • Aged, 80 and over
  • Cyclin D1 (biosynthesis)
  • Disease-Free Survival
  • Drug Resistance, Neoplasm (genetics)
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Hydro-Lyases (biosynthesis)
  • Ki-67 Antigen (biosynthesis)
  • Male
  • MicroRNAs (biosynthesis, genetics)
  • Middle Aged
  • Neoadjuvant Therapy
  • Neoplasm Metastasis
  • Prognosis
  • Sarcoma, Ewing (genetics, pathology, therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: